Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

Minors' rights to refuse medical treatment requested by their parents: remaining issues.

Journal of the American Academy of Nurse Practitioners·2002

Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity.

Journal of medicinal chemistry·2001

High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.

Journal of chromatography. B, Biomedical sciences and applications·2001

Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Journal of natural products·2001

Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

Journal of the American Chemical Society·2001

Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

Journal of medicinal chemistry·2001

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Cancer·2026

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Cancer·2026

Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study.

Cancer·2026

Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus.

Cancer·2026

Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer.

Cancer·2026

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial.

Cancer·2026

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

The Annals of pharmacotherapy·2026

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Journal of opioid management·2026

Phospholipases D: An Update on Structure-Function Relationships.

Methods in molecular biology (Clifton, N.J.)·2026

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Alcohol (Fayetteville, N.Y.)·2026

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Molecular pain·2026

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

CNS drugs·2026

Related Experiment Videos

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

Related Concept Videos

Minors' rights to refuse medical treatment requested by their parents: remaining issues.

Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity.

High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.

Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study.

Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus.

Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer.

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial.

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Phospholipases D: An Update on Structure-Function Relationships.

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Related Experiment Videos

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

Related Concept Videos

Related Articles